Results 211 to 220 of about 39,021 (326)

Delayed Aggressive Local Recurrence of Chondroblastic Osteosarcoma 3 Years After an Excellent Pathological Response: A Case Report

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Late recurrence of osteosarcoma after a prolonged disease‐free interval is an uncommon but significant clinical challenge, representing a failure of primary therapy to eradicate microscopic residual disease. We present the case of a 19‐year‐old male diagnosed with chondroblastic osteosarcoma of the proximal tibia who was treated with standard ...
Abdul Hannan, Bilal Aslam, Natasha Hastings, Deepa Lachhman Das, Zahra Sania, Marium Mansoor, Fazeela Bibi, Khalil El Abdi, Samreen Najeeb, Kristen Batten, Manisha Kumari, Said Hamid Sadat   +11 more
wiley   +1 more source

Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy. [PDF]

Clin Cancer Res
Garralda E, Abbott C, Calahorro A, Mirallas O, Pugh J, Moreno-Cárdenas AB, Keough K, Galvao V, Alonso G, Olano AM, Vieito Villar M, Oberoi A, Lostes Bardaji J, Hernando-Calvo A, Braña I, Pretelli G, Ortega B, Arenillas C, Czerniak N, Navarro FCP, Li B, Pyke RM, Ravi N, Zatse C, Grussu F, Sanz M, Viaplana C, Raskina K, Jimenez J, Fasani R, Casbas-Hernandez P, Oflazoglu E, Hodgson D, Reis-Filho J, Felip E, Élez E, Muñoz E, Dienstmann R, Tabernero J, Lopez-Perez R, Nuciforo P, Chen RO, Boyle SM, Toledo RA.   +43 more
europepmc   +1 more source

Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers

Cancer, Volume 132, Issue 1, 1 January 2026.
Abstract Background Circulating tumor DNA (ctDNA) is a valuable biomarker for assessing treatment response and molecular residual disease. In advanced esophageal and gastric cancer (gastroesophageal cancer [EGC]), ctDNA dynamics remain poorly understood.
Rutika Mehta, Samuel Rivero‐Hinojosa, Farshid Dayyani, Jenifer Ferguson, Bushra Shariff, Vasily N. Aushev, Griffin L. Budde, J. Bryce Ortiz, Giby V. George, Shruti Sharma, Adham A. Jurdi, Minetta C. Liu, Ronald L. Drengler, Samuel J. Klempner   +13 more
wiley   +1 more source

Postoperative Lymph Is a Proximal Source of ctDNA for Detection of Recurrence in HPV-Independent Head and Neck Cancer. [PDF]

Clin Cancer Res
Lazare S, Gu Z, Earland N, Harmon MA, Pacula M, Rivera M, Tellis A, Whitfield D, Benson A, Gerndt S, Harris P, Khalil L, Ramirez R, Xu Z, Wahle B, Puram S, Adkins D, Thorstad W, Zandberg D, Chernock R, Skinner H, Spector ME, Seethala R, Ferris RL, Smith JD, Greer AE, Verner EL, Georgiadis A, Sausen M, Ramkissoon SH, Jensen TJ, Francis MS, Winckler W, Chaudhuri AA, Zevallos JP.   +34 more
europepmc   +1 more source

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma [PDF]

, 2020
al., et, Bartlett, Nancy L., Cashen, Amanda, Edwin, Natasha, Ghobadi, Armin, Kahl, Brad, Mehta-Shah, Neha, Merryman, Reid W.   +7 more
core   +1 more source

Significance and Correlation Analysis of Folate Receptor‐Positive Circulating Tumor Cells (FR + CTC) in Colorectal Cancer Patients

Cancer Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background To investigate the significance of detecting folate receptor‐positive circulating tumor cells (FR + CTC) in colorectal cancer patients and to analyze their correlation with the expression of conventional tumor markers (CEA, CA199, CA125). Methods and Results A retrospective collection of preoperative FR + CTC values from patients in
Renwang Hu, Aofeng Lan, Dan Li, Can Liu
wiley   +1 more source

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas. [PDF]

ESMO Open
Filippini DM, Cabarrou B, Dupain C, Halladjian M, Coquan E, Sablin MP, Mazzarella L, Francisco M, Servant N, Tonini MM, Hundt AF, Castel-Ajgal Z, You B, Bigot F, Ghiringhelli F, Vansteene D, Gomez-Roca C, Cousin S, Lambert A, Saada-Bouzid E, Durando X, Abdeddaim C, Borel C, Chaltiel R, Borcoman E, Legrand F, Bernhart S, Jimenez M, Bièche I, Filleron T, Le Tourneau C, Kamal M, Jeannot E.   +32 more
europepmc   +1 more source

Concurrent genomic assessment of circulating tumour cells and ctDNA to guide therapy in metastatic breast cancer

Allsopp, Rebecca C., Page, Karen, Wren, Evie, Nteliopoulos, Georgios, Gleason, Kelly L. T., Lall, Gurdeep Matharu, Bhagani, Shradha, Acheampong, Emmanuel, Wadsley, Marc K., Coombes, Raoul Charles, Shaw, Jacqueline A.   +10 more
openalex   +1 more source

Multimodal investigation of dacomitinib-calf thymus DNA binding interaction: insights from spectroscopy, thermodynamics, and <i>in-silico</i> studies. [PDF]

RSC Adv
Alossaimi MA, Aldakhil T, Elmansi H, Belal F, Magdy G.   +4 more
europepmc   +1 more source

Supplementary Figure S5 from Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study

Samantha I. Liang, Zoe Quandt, Sara Wienke, Jing Wang, Sean Gordon, Reagan M. Barnett, Jude Masannat, Kyle Chang, Carin R. Espenschied, Katie Quinn, Kimberly C. Banks, Enjun Yang, John E. Connolly   +12 more
openalex   +1 more source